Design: A multicentre survey study assessed the management of pain and sedation in children aged 0-18 years after cardiac surgery.
Setting: PICUs of nineteen tertiary children's hospitals worldwide were invited to participate. The focus of the survey was on type and dose of analgesic and sedative drugs and the tools used for their pharmacodynamic assessment.
Results: Fifteen hospitals (response rate 79%) filled out the survey. Morphine was the primary analgesic in most hospitals and its doses for continuous infusion ranged from 10-60 mcg kg -1 h -1 in children aged 0-36 months. Benzodiazepines were the first choice for sedation, with midazolam used in all study hospitals. Eight hospitals (53%) reported routine use of sedatives with pain treatment. Overall, type and dosing of analgesic and sedative drugs differed substantially between hospitals. All participating hospitals used validated pain and sedation assessment tools.
Conclusion: This international survey on the treatment of pain and sedation after paediatric cardiac surgery showed a large variation in the type and dosing of drugs employed. As a consequence, there is a need to rationalize pain and sedation management for this vulnerable patient group. 
WHAT IS KNOWN ABOUT THE SUBJECT
• Opioids are widely used as primary analgesic after cardiac surgery in children.
• Current guidelines are based on small, non-randomized clinical trial, and PK/PD data is scarce.
• Validated PD tools are available, but not often mentioned in evaluating analgesics or sedatives.
WHAT THIS STUDY ADDS
• Insight into clinical protocols on use of analgesics and sedatives in children after cardiac surgery,
showing large variability in choice and dosing of analgesics and sedatives.
• morphine is mainly used as primary analgesic, midazolam is mainly used as primary sedative. Dosing of both drugs differ considerably between hospitals.
• Use of validated PD assessment tools is not standard in clinical practise. Lack of a validated PD assessment tool could result in oversedation. 
INTRODUCTION
Congenital heart disease (CHD) accounts for almost one third of all congenital defects(1). Adequate postoperative sedation and pain management is important in these patients because untreated pain can lead to a delayed recovery, prolonged adverse behavioural consequences and negative physiologic responses(2-4).
Morphine is widely used for analgesia after major surgery in neonates and children. Several studies on morphine PK/PD have resulted in age specific dosing algorithms in children after non-cardiac surgery. Ceelie et al. showed equipotency of paracetamol as primary analgesic as compared to morphine in neonates and children < 1 year of age after major non-cardiac surgery. It is currently unclear if these data can be extrapolated to children after cardiac surgery (5, 6) .
Postoperative analgosedation in children after cardiac surgery is mainly achieved with opioids combined with sedatives. The most common opioid used is morphine, with doses ranging from 5-80 mcg kg -1 h -1 (7). Morphine is recommended as drug of first choice by the Association of Paediatric Anaesthetists of Great Britain and
Ireland (8) . However, this guideline is based on small, non-randomized clinical trials. PK data are available for the routinely prescribed analgesics and sedatives, but combined PK/PD data are scarce.
Lynn et al. described adequate pain relief after cardiac surgery with continuous morphine infusions of 10-38.5 mcg kg -1 h -1 (9, 10) . Even though adequate analgesia can be achieved, plasma morphine concentrations above 20 ng ml -1 have been associated with adverse effects, such as hypotension and respiratory depression (9, 11) .
Patients with cyanotic heart defects showed lower morphine requirements and higher plasma concentrations compared to patients with non-cyanotic heart defects, indicating that type of defect or type of surgery may be associated with altered PK/PD necessitating different dosing regimens (12) .
A recent review by Lucas et al. (13) on pharmacotherapies in paediatric cardiac critical care provides an extensive overview of PK of analgesic and sedative drugs used in children after cardiac surgery but focused less on their use in protocols for clinical practice. Changes in clearance and volume of distribution (PK) and/or PD due to the use of cardiopulmonary bypass (CPB), disease processes, surgical procedure and age may alter optimal way of dosing analgesics and sedatives in children after cardiac surgery (14) . These expected PK/PD differences are not incorporated in existing guidelines and it is unclear if they are introduced into local protocols. Our primary objective was to ascertain international analgosedation practices after paediatric cardiac surgery with a self-reported survey. Our main focus was the use of local protocols, choice and dosing range of analgesics and sedatives, use of pain and sedation scores and the use of treatment algorithms.
C

METHODS
Design
A self-designed web-based survey (Monkey Survey, https://nl.surveymonkey.com/) was circulated to medical specialists in tertiary cardiac care hospitals who are responsible for the treatment of children after cardiac surgery. Hospitals were selected based on expertise and yearly conduct of more than 150 paediatric on-pump cardiac surgical procedures. The survey was designed by a small focus group consisting of a congenital cardiothoracic surgeon, three paediatric intensivists and a paediatric cardiac anaesthesiologist because of the absence of validated questionnaires. The potential respondents were instructed that this survey aimed at collecting data on the current treatment strategies concerning the use of analgesics and sedatives, as well as the tools used for the measurement of pain and sedation, according to their local protocols and not their personal preference. The survey has been provided in the appendix.
The survey focused primarily on the choice and dosing regimens of analgesic and sedative drugs prescribed in the surveyed institutions as well as the PD assessment tools that were used in these circumstances. Additional questions related to the characteristics of the unit.
Potential participants initially received a letter asking for their involvement in the survey. If they agreed details of the survey as well as the link to enter their answers were provided by email. If necessary an additional email to remind the participants about the survey was sent two and four weeks after the initial letter. Data were collected between June and August 2014.
According to the Dutch Law of research on human subjects this type of investigation in which no patients are involved neither person related questions are raised to the individual centres are not subject to ethical approval. 
RESULTS
Hospital characteristics
A total of 19 hospitals on three different continents were willing to participate; 15 (response rate 79%) hospitals completed the survey in full. Twelve respondents (80%) were from European hospitals. Three respondents were from non-European hospitals based in New-Zealand, Australia and Canada. Non-respondents were based in the USA (1), United Kingdom (2) and China (1). Respondents were physicians, mainly paediatric intensivists or paediatric cardio-anaesthesiologists who work in paediatric cardiac critical care units. Two paediatric intensivists reported that they had consulted a paediatric cardio-anaesthesiologist on questions relating to the perioperative management.
The participating hospitals perform a total of over 3000 on-pump paediatric cardio-surgical procedures annually with a post-operative ICU stay ranging between 2 and 7 days.
The number of procedures per age category varied between hospitals, however about two third of the procedures were performed in children under the age of 1 year. Table 1 shows the type and dosing of reported analgesics. Table 2 shows the type and dosing of reported sedatives. Both tables show the results for treatment protocol in neonates and children until the age of two years.
Medication
There was a wide range of choices and dosing regimens of drugs reported for both analgesics and sedatives.
Moreover, polypharmacy is often used to accomplish the desired effects for both analgesia and sedation. Eleven different analgesics and eight different sedatives were reported.
None of the hospitals based analgosedation according to protocol on cardiac diagnosis, severity scores or type of surgery. One hospital added fentanyl for analgesic therapy in patients returning from the operating room with an open sternum.
Analgesics
Opioids were the preferred analgesic; morphine was the opioid of choice in 13 (87%) of the hospitals. Dosing ranged from 10-60 mcg kg -1 h -1 for a continuous infusion and from 50-500 mcg kg -1 for a bolus dose. Morphine was supplemented with a second analgesic in 73% of hospitals, either as standard practice or rescue therapy. The primary choice of analgesics varied between hospitals but did not differ between age groups within hospitals. Most drugs were dosed according to weight. However, overall dosing ranges in neonates tended to be lower compared to infants and children. Furthermore in children over two years of age more alternative analgesic drugs were reported as used per protocol in some hospitals; namely oxycodone, nalbuphine and diclofenac.
Dexmedetomidine could be considered a sedative but was reported as an analgesic in the survey and therefore reported as such. 
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Sedation scores
All hospitals used a validated pain and sedation score. Table 3 shows the different scores used.. Pain and sedation was assessed using a total of six different paediatric pain and four different sedation scores. Eleven (73%) of the 15 hospitals used the COMFORT-B scale and Numeric Rating Scale (NRS) for pain and sedation.
Frequency of pain and sedation assessment varies between hospitals. Reassessment after an intervention, either medical or non-medical, was reported by two respondents.
Each centre reported the use of a local protocol to guide analgosedation after cardiac surgery. 
DISCUSSION
The choice and dosing regimens of analgesics and sedatives after cardiac surgery in children varied extensively across the globe. Opioids were the analgesics of choice. Morphine was the preferred analgesic drug, with a wide range of doses, both for continuous infusion and bolus administration in both the neonatal age group and in older infants and children. Morphine was supplemented by a second analgesic drug in 73% of the surveyed hospitals. Differences between local protocols were evident in all age groups, however more variation in analgesics and sedatives was found in infants and children as compared to neonates. The underlying cardiac diagnosis, severity score or type of surgery did not result in different treatment algorithms or dosing regimens.
Eight hospitals routinely used a sedative in combination with pain treatment, all other institutions started sedatives only in response to a clinical need for sedation.
The reported use of drugs are comparable with those described by Wolf in 2011, who described a broad spectrum of analgesics and sedatives that were used in children after cardiac surgery based on the guidelines Ideally we would like to predict individual morphine requirement beforehand and better categorise the efficacy of adjuvant or alternative analgesics to minimize adverse effects. By using information from PK/PD studies on morphine consumption after cardiac surgery we aim to individualize and assess treatment effect by regular pain and sedation assessment and tracking of adverse drug reactions. However, PK parameters of analgesics and sedatives, or potential PK alterations in children after cardiac surgery are currently incomplete. Changes of clearance and volume of distribution would be expected in this cohort, dependent on the use of the CPB, age and underlying pathology. Low cardiac output syndrome, fluid status or organ dysfunction may change PK/PD of drugs and all these factors may change over time. For some drugs, namely remifentanil(15, 16), dexmedetomidine (17, 18) , clonidine (19) and ketamine (20) , studies have been published within the last 10 years with PK parameters in neonates and children after cardiac surgery. However, these studies show conflicting results on PK alterations and most lack PD endpoints to assess efficacy, making it difficult to implement dose recommendations in clinical practice.
In recent years advances towards precision medicine have been made for morphine in non-cardiac surgery patients mainly focusing on the patients' size, maturation and organ function (6, 21, 22) . Using population pharmacokinetics dosing adjustments can be proposed for specific patient groups. To our knowledge, PD modelling has only been performed for opioids after non-cardiac surgery.
Due to polypharmacy it is difficult to assess the efficacy and safety of individual drugs. Our survey showed that a multimodal drug approach is often used for analgesics and sedatives. The challenge is to determine how these drugs interact (23, 24) . Also, PD aspects after cardiac surgery are rarely described, making interpretation of PK knowledge clinically limited. Validated scores are needed to adequately assess the PD endpoints of the analgesics and sedatives and to prevent overdosing and under-dosing in clinical practise. The combination of sedatives and opioids may contribute to oversedation, which is highly undesirable and could lead to longer PICU stay, longer ventilation times, drug tolerance and dependence (25) .
Validated PD scoring tools were used in our survey hospitals; mainly the Comfort-B scale (73%), VAS (47%) and the Numeric Rating Scale (26%). Interpretation of some scores can be problematic, because of poor validation in neonates and infants after cardiac surgery. Moreover, items for rises in blood pressure and heart rate are less useful in children after cardiac surgery because of the use of inotropic agents.
Frequency of assessment differed in the survey. The frequency varies between once every hour to on-demand.
Reassessment after an intervention is described by only two of the respondents. This study has several limitations. Clinical practice may deviate from protocol which might not be reflected in the survey. Also, the participating centres are all based in developed countries. Although the data from our study seem to reflect the day-to-day practice of analgosedation after cardiac surgery in children, we cannot rule out that some selection of the centres that were approached and that responded may have an effect on de diversity of the findings.
CONCLUSION
This survey shows that there is large variability in both dosing and choice of analgosedative drugs used in pediatric post cardiothoracic surgery patients especially between hospitals. This large variability reflects the complexity of analgosedation in these vulnerable patients and highlights the need for clinical studies combining PK with validated PD outcomes. Such studies are necessary to understand specific changes in this population and permit evidence-based and personalised treatment protocols. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
